Abstract
Cytokines are soluble, secreted glycoproteins that, like hormones, regulate the functions of cells and tissues. Many cytokines possess therapeutic properties and attempts to produce them in large quantities are ongoing. Transgenic plants are one system that has the potential to yield large amounts of low cost recombinant proteins. In addition, plants have the ability to introduce post-translational modifications needed for biological activity of many cytokines. In this review, we describe the efforts aimed at producing recombinant cytokines in plants and discuss some of the issues that have arisen from such activities.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Altmann F, 1997. More than silk and honey-or, can insect cells serve in the production of therapeutic glycoproteins? Glycoconj J, 5: 643–646
Banchereau J and Rybak ME, 1994. Interleukin-4. In The Cytokine handbook. Academic Press. London, pp 99–126
Batteux F, Trebeden H, Charreire J and Chiocchia G, 1999. Curative treatment of experimental autoimmune thyroiditis by in vivo administration ofplasmid DNA coding for interleukin-10. Fur J Immunol, 29: 958–963
Borden EC and Chin P, 1994. Interleukin-6: a cytokine with potential diagnostic and therapeutic roles. J Lab Clin Med, 123: 824–829
Cabanes-Macheteau M, Fitchette-Laine AC, Loutelier-Bourhis C, Lange C, Vine ND, Ma JK, Lerouge P and Faye L, 1999. N-Glycosylation of a mouse IgG expressed in transgenic tobacco plants. Glycobiology, 9: 365–372
De Meyer E and De Meyer-Guignard J, 1994. Interferons. In The Cytokine handbook. Academic Press. London, pp 265–288
De Zoeten GA, Penswick JR, Horisberger MA, Ahl P, Schultze M and Hohn T, 1989. The expression, localization, and effect of a human interferon in plants. Virology, 172: 213–222
Dieryck W, Pagnier P, Poyart C, Marden MC, Gruber V, Bournat P, Baudino S and Merot B, 1997. Human haemoglobin from transgenic tobacco. Nature 386: 29–30
Edelbaum O, Stein D, Holland N, Gafni Y, Livneh Q, Novick D, Rubinstein M and Sela I, 1992. Expression of active human interferon-beta in transgenic plants. J Interferon Res 12: 449–453
Evangelista RL, Kusnadi AR, Howard JA and Nikolov ZL, 1998. Process and economic evaluation of the extraction and purification of recombinant beta-glucuronidase from transgenic corn. Biotechnol Prog 14: 607–614
Ganz PR, Dudani AK, Tackaberry ES, Sardana R, Sauder S, Cheng XY and Altosaar I, 1996. Expression of human blood proteins in transgenic plants: the cytokine GM-CSF as a model protein. In Transgenic plants: A production system for industrial and pharmaceutical proteins, Eds. Owen MRL and Pen J, Wiley, New York. pp 281–297
Goldsmith MA and Greene WC, 1994. Interleukin-2 and the Interleukin-2 receptor, In The Cytokine handbook. Academic Press. London, pp 57–80
He ZM, Cao J, Li BJ and Huang XQ, 1998. Expression of erythropoietin gene in tomato. Acta Genetica Sinica, 25: 155–159
Hirano T, Akira S, Taga T and Kishimoto T, 1990. Biological and clinical aspects of interleukin 6. Immunol Today, 11: 443–449
Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, et al., 1986. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature, 324: 73–76
James EA, Wang C, Wang Z, Reeves R, Shin JH, Magnuson NS and Lee JM, 2000. Production and characterization of biologically active human GM-CSF secreted by genetically modified plant cells. Protein Expr Purif, 19: 131–138
Karpusas M, Nolte M, Benton CB, Meier M, Lipscomb WN and Goelz S, 1997. The crystal structure of human interferon beta at 2.2-A resolution. Proc Natl Acad Sci USA, 94: 118131 1818
Karpusas M, Whitty A, Runke L and Hochman P, 1998. The structure of human interferon-beta: implications for activity. Cell Mol Life Sci, 54: 1203–1216
Kopf M, Baumann M, Freer M, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H and Kohler H, 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature, 368: 339–342
Kopf M, Le Gros G, Coyle AJ, Kosco-Vilbois M and Brombacher F, 1995. Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol Rev, 148: 45–69
Kwon SY, Yang Y,. Hong CB and Pyun KH, 1995. Expression of active human interleukin-6 in transgenic tobacco. Mol Cells, 5: 486–492
Le HV, Ramanathan L, Labdon JE, Mays-Ichinco CA, Syto R, Arai N, Hoy P, Takebe Y, Nagabhushan TL and Trotta PP, 1988, Isolation and characterization of multiple variants of recombinant human interleukin 4 expressed in mammalian cells. J Biol Chem, 263: 1081710823
Leach MW, Davidson NJ, Fort MM, Powrie F and Rennick DM, 1999. The role of IL-10 in inflammatory bowel disease: “Of mice and men”. Toxicol Pathol, 27: 123–133
Lefebvre DD, Miki BL and Laliberte JF, 1987. Mammalian metallothionein functions in plants. Bio/Technology, 5: 1053–1056
Lerouge P, Cabanes-Macheteau M, Rayon C, Fischette-Laine CM, Gomord V and Faye L, 1998. N-glycoprotein biosynthesis in plants: recent developments and future trends. Plant Mol Biol, 38: 31–48
Ma JK, Hiatt A, Hein M, Vine ND, Wang F, Stabila P, van Dolleweerd C, Mostov K and Lehner T, 1995. Generation and assembly of secretory antibodies in plants. Science, 268: 716–719
Ma JK, Hikmat BY, Wycoff K, Vine ND, Chargelegue D, Yu L, Hein MB and Lehner T, 1998. Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nat Med, 4: 601–606
Magnuson NS, Linzmaier PM, Reeves R, An G, HayGlass K and Lee JM, 1998. Secretion of biologically active human interleukin-2 and interleukin-4 from genetically modified tobacco cells in suspension culture, Protein Expr Purif, 13: 45–52
Matsumoto S, Ikura K, Ueda M and Sasaki R, 1995. Characterization of a human glycoprotein (erythropoietin) produced in cultured tobacco cells. Plant Mol Biol, 27: 1163–1172
Matsumoto S, Ishii A, Ikura K, Ueda M and Sasaki R, 1993. Expression of human erythropoietin in cultured tobacco cells. Biosci Biotechnol Biochem, 57: 1249–1252
May LT, Ghrayeb J, Santhanam U, Tatter SB, Sthoeger Z, Helfgott DC, Chiorazzi N, Grieninger G and Sehgal PB, 1988. Synthesis and secretion of multiple forms of beta 2-interferon/B-cell differentiation factor 2/hepatocyte-stimulating factor by human fibroblasts and monocytes. J Biol Chem, 263: 7760–7766
Meager, Tony. 1998. The molecular biology of cytokines. Molecular Medical Science Series. Eds. James K and Monis A. John Wiley Sons, London
Menassa R, Jevnikar A and Brandie J, 2001. A contained system for the field production of plant recombinant proteins. In Molecularfarming. Eds. Toutant JP and Balazs E. INRA Editions, Versailles, France
Menassa R, Nguyen V, Jevnikar A and Brandie J, 2001. A self contained system for the field production of plant recombinant interleukin-10. Mol Breed, (in press)
Mire-Sluis AR, 1999. Cytokines: from technology to therapeutics. Trends Biotechnol, 17: 319–325
Mire-Sluis AR, Das RG and Padilla A, 1998. WHO cytokine standardization: facilitating the development of cytokines in research, diagnosis and as therapeutic agents. J Immunol Methods, 216: 103–116
Mire-Sluis AR and Thorpe R, 1998. Laboratory protocols for the quantitation of cytokines by bioassay using cytokine responsive cell lines. J Immunol Methods, 211: 199–210
Moore KW, O’Garra A, de Waal Malefyt R, Vieira P and Mosmann TR, 1993. Interleukin-l0. Annu Rev Immunol, 11: 165–190
Munro S and Pelham HR, 1987. A C-terminal signal prevents secretion of luminal ER proteins. Cell, 48: 899–907
Nyman TA, Kalkkinen N, Tolo H and Helin J, 1998. Structural characterisation of N-linked and 0-linked oligosaccharides derived from interferon-alpha2b and interferon-alpha14c produced by Sendai-virus-induced human peripheral blood leukocytes. Eur J Biochem, 253: 485–493
Ohara J, Coligan JE, Zoon K, Maloy WL and Paul WE, 1987. High-efficiency purification and chemical characterization of B cell stimulatory factor- 1 /interleukin 4. J Immunol, 139: 1127–1134
Orita T, Oh-eda M, Hasegawa M, Kuboniwa H, Esaki K and Ochi N, 1994. Polypeptide and carbohydrate structure of recombinant human interleukin-6 produced in Chinese hamster ovary cells. J Biochem (Tokyo), 115: 345–350
Pagny S, Cabanes-Macheteau M, Gillikin JW, Leborgne-Castel N, Lerouge P, Boston RS, Faye L and Gomord V, 2000. Protein recycling from the Golgi apparatus to the endoplasmic reticulum in plants and its minor contribution to calreticulin retention. Plant Cell, 12: 739–756
Palacpac NQ, Yoshida S, Sakai H, Kimura Y, Fujiyama K, Yoshida T and Seki T, 1999. Stable expression of human betal,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proc Natl Acad Sci USA, 96: 4692–4697
Park SM and Choo Bong Hong, 1997. Transcription of human interleukin-2 gene in Nicotiana tabacum driven by CaMV35S promoter. J Plant Biology, 40: 110–114
Pauza ME, Neal H, Hagenbaugh A, CheroutreH and Lo D, 1999. T-cell production of an inducible interleukin-l0 transgene provides limited protection from autoimmune diabetes. Diabetes, 48: 1948–1953
Pretolani M and Goldman M, 1997. IL-10 a potential therapy for allergic inflammation? Immunol Today, 18: 277–280
Radhakrishnan R, Walter LJ, Hruza A, Reichert P, Trotta PP, Nagabhushan TL and Walter MR, 1996. Zinc mediated dimer of human interferon-alpha 2b revealed by X-ray crystallography. Structure, 4: 1453–1463
Rasko JEJ and Gough NM, 1994. Granulocyte macrophage colony stimulating factor. In The Cytokine handbook. Academic Press. London, pp 343–70
Recny MA, Scoble HA and Kim Y, 1987. Structural characterization of natural human urinary and recombinant DNA-derived erythropoietin: Identification of des-arginine 166 erythropoietin. J Biol Chem, 262: 17156–17163
Refaeli Y, Van Parijs L, London CA, Tschopp J and Abbas AK, 1998. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity, 8: 615–623
Reich K, Bruck M, Grafe A, Vente C, Neumann C and Garbe C, 1998. Treatment of psoriasis with interleukin-10. J Invest Dermatol, 111: 1235–1236
Rollwagen FM and Bagar S, 1996. Oral cytokine administration. Immunol Today, 17: 548–550
Sijmons PC, Dekker BM, Schrammeijer B, Verwoerd TC, van den Elzen PJ and Hoekema A, 1990. Production of correctly processed human serum albumin in transgenic plants. Biotechnology (NY), 8: 217–221
Smirnov SP, Teverovskaia EKH, Krasheninnikova LV and Pukhal’ski VA, 1990. Design of an expression integrative vector and its application for introducing the human recombinant alfa interferon gene into plants. Genetika, 26: 2111–2121
Smith KA, 1988. Interleukin-2: inception, impact, and implications. Science, 240: 1169–1176
Tsuda E, Kawanishi G, Ueda M, Masuda S and Sasaki R, 1990. The role of carbohydrate in recombinant human erythropoietin. Eur J Biochem, 188: 405–411
Tsuji T, Nakagawa R, Sugimoto N and Fukuhara K, 1987. Characterization of disulfide bonds in recombinant proteins: reduced human interleukin 2 in inclusion bodies and its oxidative refolding. Biochemistry, 26: 3129–3134
van Ree R, Cabanes-Macheteau M, Akkerdaas J, JP Milazzo, Loutelier-Bourhis C, Rayon C, Villalba M, Koppelman S, Aalberse R, Rodriguez R, Faye L and Lerouge P, 2000. Beta (1,2)-xylose and alpha( I,3)-fucose residues have a strong contribution in IgE binding to plant glycoallergens. J Biol Chem, 275: 11451–11458
Van Snick J, 1990. Interleukin-6: an overview. Annu Rev Immunol, 8: 253–278
Vellekamp G, Cannon-Carlson S and Tang J, 1994. Purification of human interleukin-10 from a cell culture medium. US Patent # 5,328, 989
Vellekamp G, Cannon-Carlson S and Tang J, 1998. Purification of bacterially expressed human interleukin-10. US Patent 5,710, 251
Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R and Fiorentino DF, 1991. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA, 88: 1172–1176
Walsh G, 2000. Biopharmaceutical benchmarks. Nat Biotechnol, 18: 831–833
Wang A, Lu SD and Mark DF, 1984. Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues. Science, 224: 1431–1433
Wasley LC, Timony G, Murtha P, Stoudemire J, Dorner AJ, Caro J, Krieger M and Kaufman RJ, 1991. The importance of N- and 0-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Blood, 77: 2624–2632
Wee EG, Sherrier DJ, Prime TA and Dupree P, 1998. Targeting of active sialyltransferase to the plant Golgi apparatus. Plant Cell, 10: 1759–1768
Windsor WT, Syto R, Tsarbopoulos A, Zhang R, Durkin J and Baldwin S, 1993. Disulfide bond assignments and secondary structure analysis of human and murine interleukin-10. Biochemistry, 32: 8807–8815
Yang SC, Grimm EA, Parkinson DR, Carinhas J,. Fry KD, Mendiguren-Rodriguez A, Licciardcllo J, Owcn-Schaub B, Hong WK and Roth JA, 1991. Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial. Cancer Res, 51: 3669–3676
Zablackis E, York WS, Pauly M, Hantus S, Reiter WD, Chapple CC, Albersheim P and Darvill A, 1996. Substitution of L-fucose by L-galactose in cell walls of Arabidopsis muri. Science, 272: 1808–1810
Zdanov A, Schalk-Hihi C, Gustchina A, Tsang M, Weatherbee J and Wiodawer A, 1995. Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon gamma. Structure, 3: 591–601
Zheng XX, Steele AW, Nickerson PW, Steurer W, Steiger J and Strom TB, 1995. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J Immunol, 154: 5590–5600.
Zhu Z, Hughes KW, Huang L, Sun B, Liu C, Li Y, Hou Y and Li X, 1994. Expression of human alpha-interferon cDNA in transgenic rice plants. Plant Cell Tissue and Organ Culture, 36: 197–204
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Menassa, R., Jevnikar, A., Brandle, J. (2002). The Production of Recombinant Cytokines in Plants. In: Erickson, L., Yu, WJ., Brandle, J., Rymerson, R. (eds) Molecular Farming of Plants and Animals for Human and Veterinary Medicine. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-2317-6_14
Download citation
DOI: https://doi.org/10.1007/978-94-017-2317-6_14
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-6110-2
Online ISBN: 978-94-017-2317-6
eBook Packages: Springer Book Archive